Skip to main content
. 2022 Jul 29;13:953195. doi: 10.3389/fimmu.2022.953195

Table 1.

The effects of NET treatment in experimental models of sepsis.

NET treatment Sepsis model Microbial Burden Tissue Injury Survival Reference
DNase (NET digestion) CLP Increased Increased Reduced Czaikoski et al. (78)
Meng et al. (79)
DNase (NET digestion) E.Coli IP infection Increased Decreased McDonald et al. (84)
DNase (NET digestion) MRSA IT infection No effect Decreased Increased Lafrancais et al. (95)
PAD4-/- (NET inhibition) MRSA IT infection Increased Decreased No effect Lafrancais et al. (95)
Alcohol intoxication (NET inhibition) CLP Increased Reduced Jin et al. (82)
DNase (NET digestion) + Antibiotics CLP Reduced Reduced Increased Czaikoski et al. (78)
Delayed DNase (NET digestion) CLP Reduced Reduced Increased Mai et al. (98)
Disulfiram (NET inhibition) CLP Reduced Increased Silva et al. (91)
Cl-Amidine (NET inhibition) CLP Increased Biron et al. (41)
DNase (NET digestion) LPS Reduced Increased Czaikoski et al. (78)
DNase (NET digestion) LPS Reduced Liu et al. (85)

- , ‘Not Studied’ ; CLP, Cecal Ligation Puncture; LPS, lipopolysaccharide; MRSA, Methicillin-resistant Staphilococcus aureus; E.coli, Escherichia Coli; PAD4, Peptidylarginine deiminase 4; IP, intra-peritoneal; IT, intra-tracheal.